Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.210
-0.070 (-5.47%)
At close: Nov 13, 2026, 4:00 PM EST
1.060
-0.150 (-12.40%)
After-hours: Nov 13, 2026, 5:14 PM EST
Lisata Therapeutics Market Cap
Lisata Therapeutics has a market cap or net worth of $10.9 million as of November 13, 2026. It is the 40,801st most valuable company in the world and the 5,492nd biggest in the United States. Its market cap has decreased by 42.92% in one year.
Market Cap
10.90M
Enterprise Value
460.23K
1-Year Change
-42.92%
Global Rank
Country Rank
#5,492 United States
Category
ChartMarket Cap Chart
Since August 9, 2007, Lisata Therapeutics's market cap has decreased from $11.90M to $10.90M, a decrease of -8.38%. That is a compound annual growth rate of -0.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 10.90M | -33.52% |
| Dec 31, 2025 | 16.40M | -34.40% |
| Dec 31, 2024 | 25.00M | 12.61% |
| Dec 29, 2023 | 22.20M | 11.56% |
| Dec 30, 2022 | 19.90M | -60.44% |
| Dec 31, 2021 | 50.30M | 81.59% |
| Dec 31, 2020 | 27.70M | 6.13% |
| Dec 31, 2019 | 26.10M | -25.43% |
| Dec 31, 2018 | 35.00M | 5.42% |
| Dec 29, 2017 | 33.20M | 43.72% |
| Dec 30, 2016 | 23.10M | -61.37% |
| Dec 31, 2015 | 59.80M | -55.61% |
| Dec 31, 2014 | 134.70M | -27.23% |
| Dec 31, 2013 | 185.10M | 93.62% |
| Dec 31, 2012 | 95.60M | 74.77% |
| Dec 30, 2011 | 54.70M | -32.64% |
| Dec 31, 2010 | 81.20M | 43.46% |
| Dec 31, 2009 | 56.60M | 1,564.71% |
| Dec 31, 2008 | 3.40M | -46.03% |
| Dec 31, 2007 | 6.30M | -47.06% |
| Aug 9, 2007 | 11.90M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 12.00M |
| Fractyl Health | 11.99M |
| Dyadic International | 11.92M |
| Radiopharm Theranostics | 11.37M |
| Vyome Holdings | 11.09M |
| Chemomab Therapeutics | 11.09M |
| Purple Biotech | 10.96M |
| TScan Therapeutics | 10.89M |